Future directions in castrate-resistant prostate cancer therapy.
about
The biology of castration-resistant prostate cancerIn vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line.Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region.Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer.
P2860
Future directions in castrate-resistant prostate cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Future directions in castrate-resistant prostate cancer therapy.
@en
Future directions in castrate-resistant prostate cancer therapy.
@nl
type
label
Future directions in castrate-resistant prostate cancer therapy.
@en
Future directions in castrate-resistant prostate cancer therapy.
@nl
prefLabel
Future directions in castrate-resistant prostate cancer therapy.
@en
Future directions in castrate-resistant prostate cancer therapy.
@nl
P2860
P356
P1476
Future directions in castrate-resistant prostate cancer therapy
@en
P2093
Michael A Carducci
P2860
P356
10.3816/CGC.2010.N.006
P407
P577
2010-12-01T00:00:00Z